Who Is Sigyn Therapeutics?

Sigyn Therapeutics is a medical technology company headquartered in San Diego, California USA.  We were established on the belief that blood purification devices can be designed to address significant unmet needs in global health.  

A Therapeutic Candidate to Treat a Broad-Spectrum of Pathogen Related Conditions

To address unmet needs in global health, we created Sigyn Therapy, a dual-function blood purification technology that extracts pathogen sources of life-threatening inflammation in concert with the broad-spectrum elimination of inflammatory mediators that fuel sepsis, the #1 cause of hospital deaths worldwide.

More About Our Technology

An Expansive Pipeline of Therapeutic Opportunities

Our pathogen-related opportunities include but are not limited to the treatment of emerging bioterror and pandemic threats, drug-resistant pathogens (including antibiotic-resistant bacterial infections), hepatic encephalopathy and community-acquired pneumonia (CAP). CAP is the leading cause of death among infectious diseases, the leading cause of death in children under 5 years of age, and a catalyst for ~50% of sepsis and septic shock cases.

 

View Therapeutic Opportunities

50+ Years of Relevant Industry Experience

Our co-founders Jim Joyce and Craig Roberts have 50+ years of combined experience in the medical technology field. Additionally, Mr. Joyce has two decades of public company CEO and Corporate Board leadership experience.

View Management Team

View Board of Directors

View Scientific Advisory Board